Skip to content

Gene - Diet Interactions in Fatty Acid Desaturase 1 Gene

Gene - Diet Interactions in Fatty Acid Desaturase 1 Gene (FADSDIET)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02543216
Acronym
FADSDIET
Enrollment
59
Registered
2015-09-07
Start date
2015-01-31
Completion date
2015-04-30
Last updated
2015-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty Acid

Keywords

fatty acids, FADS gene, genotype, diet

Brief summary

Interactions between genes and environment, are likely to be crucial in the development of the common diseases such as type 2 diabetes. It was recently shown that FADS1 and FADS 2 genotypes are the strongest genes in a genome-wide analysis regulating serum fatty acid profile.The aim of this study is to test if subjects with the CC and TT genotypes of the FADS1 gene (rs174547) respond differentially to a diet supplemented with linoleic acid (substrate for FADS). We hypothesize that subjects with the TT genotype with more active desaturases will be more sensitive to dietary modification leading to more robust differences in serum FA profile, tissue inflammation and serum lipids.

Detailed description

Lean and overweight subjects (BMI \>20kg/m2 \<29kg/m2 ) with CC and TT genotypes of FADS1 polymorphism (rs174547) were recruited from the METSIM study (METabolic Syndrome in Men, currently \>10000 men included from the population living in Kuopio). The potential participants were asked to contact study nurse if willing to participate. Twenty six subjects with CC genotype were selected after matching with thirty six subjects with the TT genotype for age, BMI and medication. Study diet were isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (25-45 g) sunflower oil daily depending on body weight. Thus, approximately 16-28 g (6 E%) LA daily were provided on top of the average intake of approximately 10-12 g (4.5 E%). This dose of sunflower oil is not known to cause any side effects or adverse events and even higher doses have been safe. Food records were collected at the beginning (4 days) and during the third week of the study (7 days) to estimate daily intake of macronutrients and specifically of different fatty acids.

Interventions

DIETARY_SUPPLEMENTSunflower oil

Study diets were isocaloric following the habitual diet of the participants with a supplement of 30-50 ml (25-45 g) sunflower oil daily depending on body weight. Thus, approximately 16-28 g (6 E%) LA were provided daily on top of the average intake of approximately 10-12 g (4.5 E%).

Sponsors

University of Eastern Finland
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
50 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Participant of Metabolic syndrome in men (METSIM) cohort BMI 20-30 kg/m2 Healthy CC/TT genotype (rs 174547)

Exclusion criteria

Type 2 diabetes Other chronic disease

Design outcomes

Primary

MeasureTime frame
Fatty acid profile of serum lipid fractions4 weeks

Secondary

MeasureTime frame
Serum lipids an lipoproteins4 weeks
Adipose tissue biopsies4 weeks
white blood cell samples4 weeks

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026